HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,775 | +5.9% | 6,303 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $227,349 | -13.2% | 6,303 | -8.1% | 0.01% | -27.3% |
| Q1 2023 | $262,060 | -32.9% | 6,862 | 0.0% | 0.01% | -73.2% |
| Q4 2022 | $390,448 | +35.6% | 6,862 | -5.7% | 0.04% | +192.9% |
| Q3 2022 | $288,000 | -10.0% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $320,000 | +10.3% | 7,274 | 0.0% | 0.01% | +27.3% |
| Q1 2022 | $290,000 | -0.7% | 7,274 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $292,000 | -1.4% | 7,274 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $296,000 | -10.3% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $330,000 | +8.9% | 7,274 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $303,000 | -2.6% | 7,274 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $311,000 | – | 7,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |